Document is current
Any future updates will be listed below
-
Authors
Leahy, Caroline https://orcid.org/0000-0002-7080-5491
Major, Samantha
Howard, Jill
Carpenter, Kimberly L.H.
Tenenbaum, Elena
Franz, Lauren
Vermeer, Saritha
Grapel, Jordan
Compton, Scott
Spanos, Marina
Dawson, Geraldine
-
Funding
Funding for this research was provided by:
National Institute of Child Health and Human Development (P50HD093074, P50HD093074, P50HD093074, P50HD093074, P50HD093074, P50HD093074, P50HD093074, P50HD093074, P50HD093074, P50HD093074, P50HD093074)
Marcus Foundation
- License Information
-
More Information
Article History
Received: 4 February 2025
Accepted: 5 June 2025
First Online: 10 July 2025
Declarations
:
: Dr. Dawson is on the Scientific Advisory Boards of the Nonverbal Learning Disability Project, and Tris Pharma, Inc., is a consultant to Apple, Inc., and received book royalties from Guilford Press, Oxford University Press, and Springer Nature Press. Dr. Dawson has developed technology, data, and/or products that have been licensed to Apple, Inc. and Cryocell, Inc. and Dawson and Duke University have benefited financially. Dr. Dawson has received funding from the Marcus Foundation, Cord Blood Association, National Institutes of Health (NIH), and Simons Foundation. Dr. Carpenter has had funding by the National Institutes of Health (NIH), the Department of Defense, and the Brain and Behavior Foundation. Dr. Carpenter is a standing member on the Programmatic Panel for the Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Autism Research Program and has served as an ad hoc reviewer on NIH review panels; she has received reimbursement for her time on these panels. Dr. Tenenbaum is a consultant to Maplight Therapeutics. The remaining authors declare no competing interests.
